
Elinzanetant for Menopausal VMS: OASIS Lead Investigator Discusses Results, Side Effects, Next Steps
JoAnn Pinkerton, MD, details the positive findings from the OASIS 1, 2, and 3 studies of elinzanetant and highlights next steps in research.

JoAnn Pinkerton, MD, details the positive findings from the OASIS 1, 2, and 3 studies of elinzanetant and highlights next steps in research.

New data shows that favorable CV health in the first trimester is associated with a 35% to 62% lower risk of HDP regardless of level of genetic risk.

Those least likely to schedule further screening mammograms had received a false-positive with recommendation for follow-up after only a short interval.

Regulations have been amended under the Mammography Quality Standards Act of 1992 to ensure women receive quality mammography for early breast cancer detection and prevention.

Your daily dose of the clinical news you may have missed.

Obstructive sleep apnea during pregnancy increases risk for gestational hypertension and preeclampsia; CPAP therapy may lower risk significantly.

The submission is based on data from OASIS trials that showed elinzanetant significantly reduced the frequency and severity of moderate-to-severe VMS associated with menopause.

Your daily dose of the clinical news you may have missed.

Findings from a recent study highlight the need for targeted interventions to improve access to prenatal care for vulnerable populations.

Maternal mortality nearly doubled between 2018 and 2022 in the US. The Commonwealth Fund ranks states on how well they care for women.

Femlyv (norethindrone acetate and ethinyl estradiol) may expand access to contraception as an option for individuals with swallowing difficulties.

Providing postpartum scheduling support increased the odds of a primary care visit within 4 months of childbirth among women with chronic disease and improved monitoring.

The most concerning escalation in type 1, type 2, and gestational diabetes has been among the youngest women and girls, aged 15 to 19 years, report study authors.

Following the statewide order in August 2022, emergency contraceptive fills at Massachusetts pharmacies increased by 32% compared with rates in other states.

Data from a study performed during the first season the shot was available expand on clinical trial evidence and support the safety of RSVpreF, authors wrote.

Your daily dose of the clinical news you may have missed.

Your daily dose of the clinical news you may have missed.

Fiver years after ACS, a new study shows women are less likely to be on lipid lowering therapy and to meet LCL-C target levels than men.

The doubling of the diagnosis of chronic hypertension in pregnancy was accompanied by no increase in treatment rates, according to a new study.

Your daily dose of the clinical news you may have missed.

The unanimous ruling maintains nationwide access to mifepristone for medical abortion, reversing a lower court's decision to restrict availability.

In contrast, men did not face the same increased risk of cerebrovascular disease later in life, reported authors of a new study.

Your daily dose of the clinical news you may have missed.

Your daily dose of the clinical news you may have missed.

Primary care clinicians are essential to maximizing evidence-based midlife care for women, according to Professor of Obstetrics & Gynecology JoAnn Pinkerton, MD.